Your browser doesn't support javascript.
loading
Supporting Future Cannabis Policy - Developing a Standard Joint Unit: A Brief Back-Casting Exercise.
López-Pelayo, Hugo; Matrai, Silvia; Balcells-Olivero, Mercè; Campeny, Eugènia; Braddick, Fleur; Bossong, Matthijs G; Cruz, Olga S; Deluca, Paolo; Dom, Geert; Feingold, Daniel; Freeman, Tom P; Guzman, Pablo; Hindocha, Chandni; Kelly, Brian C; Liebregts, Nienke; Lorenzetti, Valentina; Manthey, Jakob; Matias, João; Oliveras, Clara; Pons, Maria Teresa; Rehm, Jürgen; Rosenkranz, Moritz; Swithenbank, Zoe; van Deurse, Luc; Vicente, Julian; Vuolo, Mike; Wojnar, Marcin; Gual, Antoni.
Affiliation
  • López-Pelayo H; Institut Clínic de Neurociències, Psychiatry and Psychology Service, Grup Recerca Addiccions Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Matrai S; Institut Clínic de Neurociències, Psychiatry and Psychology Service, Grup Recerca Addiccions Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Balcells-Olivero M; Institut Clínic de Neurociències, Psychiatry and Psychology Service, Grup Recerca Addiccions Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Campeny E; Institut Clínic de Neurociències, Psychiatry and Psychology Service, Grup Recerca Addiccions Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Braddick F; Institut Clínic de Neurociències, Psychiatry and Psychology Service, Grup Recerca Addiccions Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Bossong MG; Department of Psychiatry, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, Netherlands.
  • Cruz OS; Social Sciences Department, Instituto Universitário da Maia (ISMAI), Maia, Portugal.
  • Deluca P; University Interdisciplinary Research Centre for Human Rights - JusGov, University of Minho, Maia, Portugal and JusGov - Escola de Direito, Braga, Portugal.
  • Dom G; Addictions Department, King's College London, Institute of Psychiatry, Psychology & Neuroscience, London, United Kingdom.
  • Feingold D; Adult Psychiatry Department, Collaborative Antwerp Psychiatric Research Institute, University of Antwerp, Antwerp, Belgium.
  • Freeman TP; European Federation of Addiction Societies, Boechout, Belgium.
  • Guzman P; Department of Psychology, Ariel University, Ariel, Israel.
  • Hindocha C; Addiction and Mental Health Group, Department of Psychology, University of Bath, Bath, United Kingdom.
  • Kelly BC; Institut Clínic de Neurociències, Psychiatry and Psychology Service, Grup Recerca Addiccions Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Liebregts N; Clinical Psychopharmacology Unit, Research Department of Clinical and Health Psychology, University College London, London, United Kingdom.
  • Lorenzetti V; National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre, University College Hospital, London, United Kingdom.
  • Manthey J; Departament of Sociology, Purdue University, West Lafayette, IN, United States.
  • Matias J; Bonger Institute of Criminology, University of Amsterdam, Amsterdam, Netherlands.
  • Oliveras C; School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Fitzroy, VIC, Australia.
  • Pons MT; Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany.
  • Rehm J; Department of Psychiatry and Psychotherapy, Center for Interdisciplinary Addiction Research of Hamburg University (ZIS), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • Rosenkranz M; European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.
  • Swithenbank Z; Institut Clínic de Neurociències, Psychiatry and Psychology Service, Grup Recerca Addiccions Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic de Barcelona, Barcelona, Spain.
  • van Deurse L; Institut Clínic de Neurociències, Psychiatry and Psychology Service, Grup Recerca Addiccions Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Vicente J; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Vuolo M; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Wojnar M; Canada Epidemiological Research Unit, Canada Dalla Lana School of Public Health and Department of Psychiatry, University of Toronto (UofT), Toronto, ON, Canada.
  • Gual A; Technische Universität Dresden, Klinische Psychologie & Psychotherapie, Dresden, Germany.
Front Psychiatry ; 12: 675033, 2021.
Article in En | MEDLINE | ID: mdl-34093282
The standardization of cannabis doses is a priority for research, policy-making, clinical and harm-reduction interventions and consumer security. Scientists have called for standard units of dosing for cannabis, similar to those used for alcohol. A Standard Joint Unit (SJU) would facilitate preventive and intervention models in ways similar to the Standard Drink (SD). Learning from the SD experiences allows researchers to tackle emerging barriers to the SJU by applying modern forecasting methods. During a workshop at the Lisbon Addictions Conference 2019, a back-casting foresight method was used to address challenges and achieve consensus in developing an SJU. Thirty-two professionals from 13 countries and 10 disciplines participated. Descriptive analysis of the workshop was carried out by the organizers and shared with the participants in order to suggest amendments. Several characteristics of the SJU were defined: (1) core values: easy-to use, universal, focused on THC, accurate, and accessible; (2) key challenges: sudden changes in patterns of use, heterogeneity of cannabis compounds as well as in administration routes, variations over time in THC concentrations, and of laws that regulate the legal status of recreational and medical cannabis use); and (3) facilitators: previous experience with standardized measurements, funding opportunities, multi-stakeholder support, high prevalence of cannabis users, and widespread changes in legislation. Participants also identified three initial steps for the implementation of a SJU by 2030: (1) Building a task-force to develop a consensus-based SJU; (2) Expanded available national-level data; (3) Linking SJU consumption to the concept of "risky use," based on evidence of harms.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Psychiatry Year: 2021 Document type: Article Affiliation country: Spain Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Psychiatry Year: 2021 Document type: Article Affiliation country: Spain Country of publication: Switzerland